Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2019, Vol. 33 ›› Issue (3): 79-87.doi: 10.6040/j.issn.1673-3770.1.2019.008

• Original Article • Previous Articles     Next Articles

Association of Toll-like receptor pathway gene polymorphisms with allergic rhinitis

Ruoxi CHEN1,Qingzhao ZHANG1,Meiping LU1,Xinjie ZHU1,Lei CHENG1,2,3()   

  1. 1. Department of Otorhinolaryngology, The First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, Jiangsu, China
    2. International Centre for Allergy Research, Nanjing Medical University, Nanjing 210029, Jiangsu, China
    3. The Institute of Allergy and Autoimmune Disease,Jiangsu Clinical Medicine Research Institution,Nanjing 210029,Jiangsu,China
  • Received:2019-02-15 Revised:2019-05-06 Online:2019-05-20 Published:2019-08-07
  • Contact: Lei CHENG E-mail:chenglei@jsph.org.cn

Abstract: Objective

The involvement of the Toll-like receptor (TLR) signaling pathway in allergic rhinitis (AR), asthma, and other allergic diseases is being intensively studied. The present study assessed the correlation between TLR pathway gene single nucleotide polymorphisms (SNPs) and incidence of AR, and investigated the influence of SNPs in the pathogenesis of AR.

Methods

Candidate TLR pathway SNPs were screened by a search of a bioinformatics database system using the TaqMan SNP genotyping system as part of a hospital-based case-control study of 452 AR patients and 491 healthy controls. Serum levels of eosinophil cationic protein, total IgE, and allergen-specific IgE were measured by the Immuno CAP blood test.

Results

Six SNPs were identified (TLR2 rs7656411, rs76112010, rs7682814 and CD14 rs2563298, rs2569190, rs2569191). Genotype frequencies of CD14 rs2563298 and rs2569191 were significantly different between the cases and controls (P<0.05). AR patients with asthma were significantly associated with the rs7656411, rs2563298, and rs2569191. Genotype frequencies of TLR2 rs7656411 were significantly different between controls and the male and history case subgroups. Significant differences were also found in genotypes of CD14 rs2563298 and rs2569191 compared with control and subgroups of cases. Gene interaction analysis revealed a three-locus interaction involving TLR2 rs7656411, CD14 rs2563298, and CD14 rs2569191 in AR cases.

Conclusion

Polymorphisms of TLR2 and CD14 in the TLR pathway may contribute to susceptibility of AR in this Chinese population.

Key words: Allergic rhinitis, Toll-like receptors, CD14, Single nucleotide polymorphism, Genetic association studies

CLC Number: 

  • R765.21

Table 1

Primary information of TLR2 and CD14 SNPs"

序号 SNPs 染色体位置 碱基变化 最小等位基因(MAF) HWE P a
数据库 病例组 对照组
1 rs7656411 3′near gene G/T 0.419 0.482 0.451 0.168
2 rs76112010 5′near gene A/G 0.136 0.203 0.169 0.661
3 rs7682814 5′near gene A/G 0.167 0.202 0.172 0.286
4 rs2563298 3′UTR A/C 0.151 0.123 0.184 0.067
5 rs2569190 5′UTR A/T 0.500 0.380 0.412 0.988
6 rs2569191 5′near gene C/T 0.453 0.363 0.426 0.625

Table 2

Distribution of selected variables between cases and controls"

变量 病例组 (n = 452) 对照组 (n = 495) P
年龄 (岁, x ˉ ± s ) 19.70 ± 12.60 20.10 ± 12.61 0.597a
性别[n(%)]
302(66.8) 303(61.2) 0.073a
150(33.2) 192(38.8)
鼻炎病程 (年, x ˉ ± s ) 6.62 ± 5.87
鼻腔总症状 ( x ˉ ± s ) 5.25 ± 2.39
血清总IgE [kU/L, M (IQR)] 264.0 (120.6~593.5) 26.8 (11.1~52.2) < 0.001b
特异性IgE [kUA/L, M (IQR)]
屋尘螨 29.0(4.6~72.5)
粉尘螨 24.1 (5.0~69.9)
ECP [μg/L, median(IQR)] 12.7 (5.2~28.7) 4.6 (3.1~7.5) < 0.001b
伴随哮喘
118(26.1)
271(60.0)
家族史
122(27.0)
269(59.5)

Table 3

Genotypes and allele frequencies of TLR2 and CD14 polymorphisms among cases and controls"

SNPs 基因型 病例组 对照组 Crude OR(95%CI)

Adjusted OR

(95%CI)a

P b
n % n %
TLR2
rs7656411 n = 441 n =493
GG 112 25.4 156 31.6 1.00 (reference) 1.00 (reference) 0.079
GT 233 52.8 229 46.5 1.42 (1.05~1.92) 1.41 (1.04~1.91)
TT 96 21.8 108 21.9 1.23 (0.86~1.79) 1.22 (0.84~1.76)
GT/TT 329 74.6 337 68.4 1.36 (1.02~1.81) 1.35 (1.01~1.79) 0.035
T allele 0.451 0.186
rs76112010 n = 446 n = 485
GG 287 64.4 331 68.3 1.00 (reference) 1.00 (reference) 0.144
GA 137 30.7 141 29.1 1.12 (0.84~1.49) 1.15 (0.86~1.53)
AA 22 4.96 13 2.7 1.95 (0.97~3.95) 1.98 (0.98~4.02)
GA/AA 159 35.7 154 31.2 1.19 (0.91~1.53) 1.22 (0.93~1.60) 0.209
A allele 0.203 0.089
rs7682814 n = 441 n = 486
GG 285 64.6 330 67.9 1.00 (reference) 1.00 (reference) 0.074
GA 134 30.4 145 29.8 1.07 (0.81~1.42) 1.09 (0.82~1.45)
AA 22 5.00 11 2.26 2.32 (1.10~4.86) 2.29 (1.09~4.81)
GA/AA 42 15.9 38 13.9 1.15 (0.88~1.52) 1.17 (0.90~1.55) 0.292
A allele 0.202 0.097
CD14
rs2563298 n = 434 n =479
CC 336 77.4 326 68.1 1.00 (reference) 1.00 (reference) 0.003
CA 89 20.5 131 27.3 0.66 (0.48~0.90) 0.65 (0.48~0.89)
AA 9 2.1 22 4.60 0.40 (0.18~0.88) 0.40 (0.18~0.89)
CA/AA 98 68.5 153 31.9 0.62 (0.46~0.84) 0.62 (0.46~0.83) 0.002
A allele 0.123 <0.001
rs2569190 n = 450 n = 481
AA 174 38.7 166 34.5 1.00 (reference) 1.00 (reference) 0.351
AG 210 46.7 233 48.4 0.86 (0.65~1.14) 0.86 (0.64~1.15)
GG 66 14.7 82 17.1 0.78 (0.88~1.92) 0.76 (0.52~1.94)
AG/GG 276 61.3 315 65.5 0.84 (0.52~1.31) 0.84 (0.64~1.09) 0.188
G allele 0.380 0.150
rs2569191 n = 441 n = 472
CC 187 42.4 153 32.4 1.00 (reference) 1.00 (reference) 0.008
CT 188 42.6 236 50.0 0.65 (0.49~0.87) 0.65 (0.48~0.87)
TT 66 15.0 83 17.6 0.65 (0.44~0.96) 0.64 (0.44~0.95)
CT/TT 254 57.6 319 67.6 0.65 (0.50~0.85) 0.65 (0.49~0.85) 0.002
T allele 0.363 0.006

Table 4

Stratification analyses of TLR2 and CD14 polymorphisms in MW/MM genotype in AR subgroups"

变量 分组 rs7656411 病例/对照 rs2563298 病例/对照 rs2569191 病例/对照
例数

Adjusted OR

(95%CI)b

例数

Adjusted OR

(95%CI)b

例数

Adjusted OR

(95%CI)b

年龄(岁) <18 247/239 1.33(0.88~1.99) 244/239 0.54(0.36~0.80) 247/236 0.65(0.44~0.94)
≥18 194/254 1.36(0.91~2.06) 191/240 0.73(0.47~1.13) 194/236 0.66(0.44~0.98)
性别 295/303 1.60(1.12~2.30) 289/296 0.75(0.52~1.07) 293/289 0.66(0.47~0.93)
146/190 0.97(0.60~1.57) 146/183 0.42(0.25~0.72) 148/183 0.62(0.40~0.98)
哮喘 263/493 1.28(0.81~2.03) 261/479 0.45(0.27~0.75) 262/472 0.53(0.35~0.81)
116/493 1.61(1.13~2.28) 115/479 0.60(0.42~0.85) 116/472 0.70(0.51~0.96)
家族史 120/493 1.20(0.76~1.89) 118/479 0.56(0.35~0.92) 120/472 0.85(0.56~1.31)
260/493 1.64(1.16~2.33) 260/479 0.55(0.38~0.79) 260/472 0.57(0.42~0.78)
VAS <5 247/493 1.25(0.88~1.77) 241/479 0.65(0.45~0.92) 246/472 0.72(0.52~0.99)
≥5 194/493 1.45(0.99~2.12) 193/479 0.60(0.40~0.88) 195/472 0.57(0.41~0.80)
IgE a 135/493 1.41(0.99~2.00) 234/479 0.45(0.31~0.67) 237/472 0.61(0.44~0.84)
206/493 1.31(0.90~1.89) 200/479 0.82(0.57~1.19) 204/472 0.71(0.50~0.99)

Table 5

Multifactor dimensionality reduction models for locus-locus interactions"

模型a 训练样本准确度 检测样本准确度

交叉验证一致

P
A6 0.5491 0.5264 8/10 0.0036
A3 A6 0.5712 0.5196 8/10 < 0.0001
A1 A4 A6 0.5953 0.5487 8/10 < 0.0001

Fig.1

Tree diagram of the best genotype models. The distance between SNPs indicates the intensity of the interactions. The colors indicate the type of interactions. Red, orange, and green denotes a high degree, lesser degree, and weak interaction, respectively"

1 Bousquet J , Khaltaev N , Cruz AA , et al . Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)[J]. Allergy, 2008, 63(Suppl 86): 8-160. doi:10.1111/j.1398-9995.2007.01620.x .
doi: 10.1111/j.1398-9995.2007.01620.x
2 Zhang L , Han DM , Huang D , et al . Prevalence of self-reported allergic rhinitis in eleven major cities in china[J]. Int Arch Allergy Immunol, 2009, 149(1): 47-57. doi:10.1159/000176306 .
doi: 10.1159/000176306
3 Linneberg A , Henrik Nielsen N , Frølund L , et al . The link between allergic rhinitis and allergic asthma: a prospective population-based study. The copenhagen allergy study[J]. Allergy, 2002, 57(11): 1048-1052. doi: 10.1034/j.1398-9995.2002.23664.x
doi: 10.1034/j.1398-9995.2002.23664.x
4 Bugiani M , Carosso A , Migliore E , et al . Allergic rhinitis and asthma comorbidity in a survey of young adults in Italy[J]. Allergy, 2005, 60(2): 165-170. doi:10.1111/j.1398-9995.2005.00659.x .
doi: 10.1111/j.1398-9995.2005.00659.x
5 Leynaert B , Neukirch F , Demoly P , et al . Epidemiologic evidence for asthma and rhinitis comorbidity[J]. J Allergy Clin Immunol, 2000, 106(5 Suppl): S201-S205. doi: 10.1067/mai.2000.110151 .
doi: 10.1067/mai.2000.110151
6 Cookson W . The alliance of genes and environment in asthma and allergy[J]. Nature, 1999, 402(6760 Suppl): B5-11. doi: 10.1038/35037002 .
doi: 10.1038/35037002
7 Barnes KC . Evidence for common genetic elements in allergic disease[J]. J Allergy Clin Immunol, 2000, 106(5 Suppl): S192-S200. doi: 10.1067/mai.2000.110150 .
doi: 10.1067/mai.2000.110150
8 Grossman J . One airway, one disease[J]. Chest, 1997, 111(2 Suppl): 11S-16S. PMID: 9042022.
9 Zarember KA , Godowski PJ . Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines[J]. J Immunol, 2002, 168(2): 554-561. doi: 10.4049/jimmunol.169.2.1136 .
doi: 10.4049/jimmunol.169.2.1136
10 Chuang TH , Ulevitch RJ . Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8 and hTLR9[J]. Eur Cytokine Netw, 2000, 11(3): 372-378. doi:10.1093/embo-reports/kvd058 .
doi: 10.1093/embo-reports/kvd058
11 Zhou C , Kang XD , Chen Z . A synthetic Toll-like receptor 2 ligand decreases allergic immune responses in a mouse rhinitis model sensitized to mite allergen[J]. J Zhejiang Univ Sci B, 2008, 9(4): 279-285. doi:10.1631/jzus.B0730029 .
doi: 10.1631/jzus.B0730029
12 Patel M , Xu DM , Kewin P , et al . TLR2 agonist ameliorates established allergic airway inflammation by promoting Th1 response and not via regulatory T cells[J]. J Immunol, 2005, 174(12): 7558-7563. doi: 10.4049/jimmunol.174.12.7558 .
doi: 10.4049/jimmunol.174.12.7558
13 Liu CF , Drocourt D , Puzo G , et al . Innate immune response of alveolar macrophage to house dust mite allergen is mediated through TLR2/-4 co-activation[J]. PLoS One, 2013, 8(10): e75983. doi:10.1371/journal.pone. 0075983 .
doi: 10.1371/journal.pone. 0075983
14 Crellin NK , Garcia RV , Hadisfar O , et al . Human CD4+ T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4+CD25+ T regulatory cells[J]. J Immunol, 2005, 175(12): 8051-8059. doi: 10.4049/jimmunol.175.12.8051 .
doi: 10.4049/jimmunol.175.12.8051
15 Xu DM , Liu HY , Komai-Koma M . Direct and indirect role of Toll-like receptors in T cell mediated immunity[J]. Cell Mol Immunol, 2004, 1(4): 239-246. PMID: 16225766.
16 Xirakia C , Koltsida O , Stavropoulos A , et al . Toll-like receptor 7-triggered immune response in the lung mediates acute and long-lasting suppression of experimental asthma[J]. Am J Respir Crit Care Med, 2010, 181(11): 1207-1216. doi:10.1164/rccm.200908-1255OC .
doi: 10.1164/rccm.200908-1255OC
17 Serebrisky D , Teper AA , Huang CK , et al . CpG oligodeoxynucleotides can reverse Th2-associated allergic airway responses and alter the B7.1/B7.2 expression in a murine model of asthma[J]. J Immunol, 2000, 165(10): 5906-5912. doi:10.4049/jimmunol.165.10.5906 .
doi: 10.4049/jimmunol.165.10.5906
18 Rhee CS , Libet L , Chisholm D , et al . Allergen-independent immunostimulatory sequence oligodeoxynucleotide therapy attenuates experimental allergic rhinitis[J]. Immunology, 2004, 113(1): 106-113. doi:10.1111/j.1365-2567. 2004.01930.x .
doi: 10.1111/j.1365-2567. 2004.01930.x
19 Narayanan KB , Park HH . Toll/interleukin-1 receptor (TIR) domain-mediated cellular signaling pathways[J]. Apoptosis, 2015, 20(2): 196-209. doi:10.1007/s10495-014-1073-1 .
doi: 10.1007/s10495-014-1073-1
20 Qiao H , Andrade MV , Lisboa FA , et al . FcepsilonR1 and toll-like receptors mediate synergistic signals to markedly augment production of inflammatory cytokines in murine mast cells[J]. Blood, 2006, 107(2): 610-618. doi:10.1182/blood-2005-06-2271 .
doi: 10.1182/blood-2005-06-2271
21 Nigo YI, Yamashita M , Hirahara K , et al . Regulation of allergic airway inflammation through Toll-like receptor 4-mediated modification of mast cell function[J]. Proc Natl Acad Sci USA, 2006, 103(7): 2286-2291. doi:10.1073/pnas.0510685103 .
doi: 10.1073/pnas.0510685103
22 Compton T , Kurt-Jones EA , Boehme KW , et al . Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2[J]. J Virol, 2003, 77(8): 4588-4596. doi: 10.1128/jvi.77.8.4588-4596.2003 .
doi: 10.1128/jvi.77.8.4588-4596.2003
23 Kormann MS , Depner M , Hartl D , et al . Toll-like receptor heterodimer variants protect from childhood asthma[J]. J Allergy Clin Immunol, 2008, 122(1): 86-92, 92.e1-8. doi:10.1016/j.jaci.2008.04.039 .
doi: 10.1016/j.jaci.2008.04.039
24 Qian FH , Zhang Q , Zhou LF , et al . Polymorphisms in the toll-like receptor 2 subfamily and risk of asthma: a case-control analysis in a Chinese population[J]. J Invest Allergol Clin Immunol, 2010, 20(4): 340-346. doi: 10.1089/jir.2009.0014 .
doi: 10.1089/jir.2009.0014
25 Noguchi E , Nishimura F , Fukai H , et al . An association study of asthma and total serum immunoglobin E levels for Toll-like receptor polymorphisms in a Japanese population[J]. Clin Exp Allergy, 2004, 34(2): 177-183. doi: 10.1111/j.1365-2222.2004.01839.x .
doi: 10.1111/j.1365-2222.2004.01839.x
26 Møller-Larsen S , Nyegaard M , Haagerup A , et al . Association analysis identifies TLR7 and TLR8 as novel risk genes in asthma and related disorders[J]. Thorax, 2008, 63(12): 1064-1069. doi:10.1136/thx.2007.094128 .
doi: 10.1136/thx.2007.094128
27 Smit LA , Siroux V , Bouzigon E , et al . CD14 and toll-like receptor gene polymorphisms, country living, and asthma in adults[J]. Am J Respir Crit Care Med, 2009, 179(5): 363-368. doi:10.1164/rccm.200810-1533OC .
doi: 10.1164/rccm.200810-1533OC
28 Tewfik MA , Bossé Y , Lemire M , et al . Polymorphisms in interleukin-1 receptor-associated kinase 4 are associated with total serum IgE[J]. Allergy, 2009, 64(5): 746-753. doi:10.1111/j.1398-9995.2008.01889.x .
doi: 10.1111/j.1398-9995.2008.01889.x
29 Savenije OE , Mahachie John JM , Granell R , et al . Association of IL33-IL-1 receptor-like 1 (IL1RL1) pathway polymorphisms with wheezing phenotypes and asthma in childhood[J]. J Allergy Clin Immunol, 2014, 134(1): 170-177. doi:10.1016/j.jaci.2013.12.1080 .
doi: 10.1016/j.jaci.2013.12.1080
30 Kang I , Oh YK , Lee SH , et al . Identification of polymorphisms in the Toll-like receptor gene and the association with allergic rhinitis[J]. Eur Arch Otorhinolaryngol, 2010, 267(3): 385-389. doi:10.1007/s00405-009-1100-y .
doi: 10.1007/s00405-009-1100-y
31 Senthilselvan A , Rennie D , Chénard L , et al . Association of polymorphisms of toll-like receptor 4 with a reduced prevalence of hay fever and atopy[J]. Ann Allergy Asthma Immunol, 2008, 100(5): 463-468. doi:10.1016/S1081-1206(10)60472-3 .
doi: 10.1016/S1081-1206(10)60472-3
32 Nilsson D , Andiappan AK , Halldén C , et al . Toll-like receptor gene polymorphisms are associated with allergic rhinitis: a case control study[J]. BMC Med Genet, 2012, 13: 66. doi:10.1186/1471-2350-13-66 .
doi: 10.1186/1471-2350-13-66
33 Liang XH , Cheung W , Heng CK , et al . Absence of the toll-like receptor 4 gene polymorphisms Asp299Gly and Thr399Ile in Singaporean Chinese[J]. Ther Clin Risk Manag, 2005, 1(3): 243-246. PMID: 18360565.
34 Bousquet PJ , Combescure C , Neukirch F , et al . Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines[J]. Allergy, 2007, 62(4): 367-372. doi:10.1111/j.1398-9995.2006.01276.x .
doi: 10.1111/j.1398-9995.2006.01276.x
35 Basu S , Fenton MJ . Toll-like receptors: function and roles in lung disease[J]. Am J Physiol Lung Cell Mol Physiol, 2004, 286(5): L887-L892. doi:10.1152/ajplung.00323.2003 .
doi: 10.1152/ajplung.00323.2003
36 Velasco G , Campo M , Manrique OJ , et al . Toll-like receptor 4 or 2 agonists decrease allergic inflammation[J]. Am J Respir Cell Mol Biol, 2005, 32(3): 218-224. doi:10.1165/rcmb.2003-0435OC .
doi: 10.1165/rcmb.2003-0435OC
37 Redecke V , Häcker H , Datta SK , et al . Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma[J]. J Immunol, 2004, 172(5): 2739-2743. doi: https://doi.org/10.4049/jimmunol.172.5.2739 .
doi: 10.4049/jimmunol.172.5.2739
38 Fuertes E , Brauer M , MacIntyre E , et al . Childhood allergic rhinitis, traffic-related air pollution, and variability in the GSTP1, TNF, TLR2, and TLR4 genes: results from the TAG Study[J]. J Allergy Clin Immunol, 2013, 132(2): 342-352.e2. doi:10.1016/j.jaci.2013.03.007 .
doi: 10.1016/j.jaci.2013.03.007
39 Smit LA , Siroux V , Bouzigon E , et al . CD14 and toll-like receptor gene polymorphisms, country living, and asthma in adults[J]. Am J Respir Crit Care Med, 2009, 179(5): 363-368. doi:10.1164/rccm.200810-1533OC .
doi: 10.1164/rccm.200810-1533OC
40 Smit LA , Bongers SI, Ruven HJ , et al . Atopy and new-onset asthma in young Danish farmers and CD14, TLR2, and TLR4 genetic polymorphisms: a nested case-control study[J]. Clin Exp Allergy, 2007, 37(11): 1602-1608. doi:10.1111/j.1365-2222.2007.02831.x .
doi: 10.1111/j.1365-2222.2007.02831.x
41 Lachheb J , Dhifallah IB , Chelbi H , et al . Toll-like receptors and CD14 genes polymorphisms and susceptibility to asthma in Tunisian children[J]. Tissue Antigens, 2008, 71(5): 417-425. doi:10.1111/j.1399-0039.2008.01011.x .
doi: 10.1111/j.1399-0039.2008.01011.x
42 Hussein YM , Awad HA , Shalaby SM , et al . Toll-like receptor 2 and Toll-like receptor 4 polymorphisms and susceptibility to asthma and allergic rhinitis: a case-control analysis[J]. Cell Immunol, 2012, 274(1/2): 34-38. doi:10.1016/j.cellimm.2012.02.006 .
doi: 10.1016/j.cellimm.2012.02.006
43 Ortiz-Martínez MG , Frías-Belén O , Nazario-Jiménez S , et al . A case-control study of innate immunity pathway gene polymorphisms in Puerto Ricans reveals association of toll-like receptor 2 +596 variant with asthma[J]. BMC Pulm Med, 2016, 16(1): 112. doi:10.1186/s12890-016-0272-7 .
doi: 10.1186/s12890-016-0272-7
44 Gao YF , Xiao HY , Wang YB , et al . Association of single-nucleotide polymorphisms in toll-like receptor 2 gene with asthma susceptibility: a meta-analysis[J]. Medicine (Baltimore), 2017, 96(20): e6822. doi:10.1097/MD. 0000-000000006822 .
doi: 10.1097/MD. 0000-000000006822
45 Nabih ES , Kamel HF , Kamel TB . Association between CD14 polymorphism (-1145G/A) and childhood bronchial asthma[J]. Biochem Genet, 2016, 54(1): 50-60. doi:10.1007/s10528-015-9699-4 .
doi: 10.1007/s10528-015-9699-4
46 Micheal S , Minhas K , Ishaque M , et al . Promoter polymorphisms of the CD14 gene are associated with atopy in Pakistani adults[J]. J Invest Allergy Clin Immunol, 2011, 21(5): 394-397. doi: 10.1080/09593330902990089 .
doi: 10.1080/09593330902990089
47 Penders J , Thijs C , Mommers M , et al . Host-microbial interactions in childhood atopy: toll-like receptor 4 (TLR4), CD14, and fecal Escherichia coli[J]. J Allergy Clin Immunol, 2010, 125(1): 231-236.e1-5. doi:10.1016/j.jaci. 2009. 10.011 .
doi: 10.1016/j.jaci. 2009. 10.011
48 Takeuchi K , Suzuki S , Yagawa M , et al . A CD14 gene polymorphism is associated with the IgE level for Dermatophagoides pteronyssinus[J]. Acta Otolaryngol, 2005, 125(9): 966-971. doi:10.1080/00016480510044197 .
doi: 10.1080/00016480510044197
49 Chen ML , Zhao H , Huang QP , et al . Single nucleotide polymorphisms of IL-13 and CD14 genes in allergic rhinitis: a meta-analysis[J]. Eur Arch Otorhinolaryngol, 2018, 275(6): 1491-1500. doi:10.1007/s00405-018-4975-7 .
doi: 10.1007/s00405-018-4975-7
50 Han DM , She WY , Zhang L . Association of the CD14 gene polymorphism C-159T with allergic rhinitis[J]. Am J Rhinol Allergy, 2010, 24(1): e1-e3. doi:10.2500/ajra. 2010.24.3411 .
doi: 10.2500/ajra. 2010.24.3411
51 Leung TF , Tang NL , Sung YM , et al . The C-159T polymorphism in the CD14 promoter is associated with serum total IgE concentration in atopic Chinese children[J]. Pediatr Allergy Immunol, 2003, 14(4): 255-260. doi: 10. 1034/j.1399-3038.2003.00048.x .
doi: 10. 1034/j.1399-3038.2003.00048.x
52 Wang ZY , Sundy JS , Foss CM , et al . Racial differences in the association of CD14 polymorphisms with serum total IgE levels and allergen skin test reactivity[J]. J Asthma Allergy, 2013, 6: 81-92. doi:10.2147/JAA.S42695 .
doi: 10.2147/JAA.S42695
53 Kabesch M , Hasemann K , Schickinger V , et al . A promoter polymorphism in the CD14 gene is associated with elevated levels of soluble CD14 but not with IgE or atopic diseases[J]. Allergy, 2004, 59(5): 520-525. doi:10. 1111/j.1398-9995.2004.00439.x .
doi: 10. 1111/j.1398-9995.2004.00439.x
54 Kutsenko NL , Izmailova OV , Vesnina LE, et al . [Relationship of toll-like receptors 2 and 4 genes polymorphisms with allergic diseases with increased levels of specific IgE][J]. Tsitol Genet, 2012, 46(6): 59-66. PMID: 23285751.
55 Koppelman GH , Reijmerink NE , Colin Stine O , et al . Association of a promoter polymorphism of the CD14 gene and atopy[J]. Am J Respir Crit Care Med, 2001, 163(4): 965-969. doi:10.1164/ajrccm.163.4.2004164 .
doi: 10.1164/ajrccm.163.4.2004164
56 Varadaradjalou S , Féger F , Thieblemont N , et al . Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells[J]. Eur J Immunol, 2003, 33(4): 899-906. doi:10.1002/eji.200323830 .
doi: 10.1002/eji.200323830
57 de Guia RM , Echavez MD , Gaw EL , et al . Multifactor-dimensionality reduction reveals interaction of important gene variants involved in allergy[J]. Int J Immunogenet, 2015, 42(3): 182-189. doi:10.1111/iji.12200 .
doi: 10.1111/iji.12200
58 Choi WA , Kang MJ , Kim YJ , et al . Gene-gene interactions between candidate gene polymorphisms are associated with total IgE levels in Korean children with asthma[J]. J Asthma, 2012, 49(3): 243-252. doi:10.3109/02770903.2012.660294 .
doi: 10.3109/02770903.2012.660294
[1] LYU Qian, TANG Yuan, GU Zijun, SHI Sailei, LIU Ping, WAN Wenjin. Current status of benefit finding among patients with allergic rhinitis and its influence factors [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 21-28.
[2] GU Min, LU Meiping. Advances in the application of nanomedicine delivery systems in allergen immunotherapy for allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 106-111.
[3] QIN Nana, LI Yufen, SUN Yuhao, WEI Jian, LI Qin. Effect of interleukin-13 receptor-α2 on nasal mucosal remodeling in rats with allergic rhinitis by TGF-β1/Smad signaling pathway [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 71-77.
[4] DU Kangli, ZHENG Zhenyu, XU Zhanjiang, ZHANG Yu, CHEN Lu, LU Mengyao. Construction and validation of risk prediction model for nasal septal deviation complicated with chronic sinusitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 78-86.
[5] XIONG Qin, ZHANG Yan, WU Rina, LI Feng, TANG Lixing. Application of intranasal corticosteroids in pediatrics [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 160-167.
[6] XU Xuemeng, FAN Lei, YU Wangbo, JIANG Zhiyue, PAN Chen, HUANG Yongqin. Meta-analysis of the efficacy of omalizumab in combination with specific immunotherapy for allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 26-33.
[7] HUANG Huan, HUA Hongli, DENG Yuqin, JIANG Chengyang, WANG Yuwei, YANG Xinghai. Correlation of allergic rhinitis, tonsil adenoid hypertrophy, and sinusitis in children and analysis of its clinical guiding value [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 34-41.
[8] LIU Yijun, GU Yue, GUAN Dayu, YANG Yucheng, SHEN Yang. The long-term clinical efficacy and safety of vidian neurectomy in refractory allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 42-48.
[9] ZHANG Ting, WANG Meilan, GAO Yingqin. Research progress of IL-35 in allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 139-147.
[10] ZHANG Zhuping, PENG Zican, XIAO Zhenlong, LI Cheng, YU Di, WANG Xinglong, CHEN Wei, Guo Bei. The value of a novel nasal secretion eosinophil cationic protein-myeloperoxidase test paper assay in allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(3): 129-134.
[11] LIU Chang, YANG Jingpu, GAO Yu, WANG Wenjia. Analysis of allergen detection results in children with allergic rhinitis in the Changchun area [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 51-58.
[12] ZHOU Heqing, SHEN Qi. Research progress on biomarkers of traditional Chinese medicine in the treatment of allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 168-176.
[13] WANG Manxian, ZHENG Quan, YANG Liang. Research progress in the treatment of allergic rhinitis with bacterial lysates [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(1): 141-145.
[14] LIU Chang, FANG Hongyan, LIU Xiao, FU Dongna, WANG He, WANG Jing, YANG Jingpu. Analysis of sensitization characteristics of Artemisia pollen in autumn allergic rhinitis in the Changchun area of China [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(5): 13-19.
[15] ZHANG Jie, CHEN Min, SHEN Zhengzheng, WU Yuhua, LIU Yuanhu, SUN Hao, TAN Xinhua, NI Shuren, YANG Shuxun, SHI Xuezheng, NI Xin. Study on the correlation between allergic rhinitis and coronavirus disease-2019 infection and symptoms in children [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(4): 36-42.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!